Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

Blood (2024) 143 (22): 2284–2299.

https://doi.org/10.1182/blood.2023021640

Published: 2024

Includes: Supplemental data

Journal Articles

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Blood (2023) 142 (Supplement 1): 850.

https://doi.org/10.1182/blood-2023-190851

Published: 2023

Journal Articles

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2023-178059

Published: 2023

Journal Articles

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Blood (2023) 142 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2023-174325

Published: 2023

Journal Articles

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Blood (2023) 142 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2023-174384

Published: 2023

Journal Articles

Immune Responses after One Versus Two Influenza A/B Vaccinations in Patients with Multiple Myeloma

Julius Enssle, Tonio Brinkschmidt, Ralf Dürrwald, Sebastian Wolf, David Zurmeyer, Björn Steffen, Evelyn Ullrich, Hubert Serve, Thomas Oellerich, Ivana von Metzler

Blood (2023) 142 (Supplement 1): 4737.

https://doi.org/10.1182/blood-2023-180096

Published: 2023

Journal Articles

Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

Andy Itsara, Sebastian Scheich, Björn Häupl, Xin Yu, Thomas Oellerich, Louis M. Staudt

Blood (2022) 140 (Supplement 1): 6394–6395.

https://doi.org/10.1182/blood-2022-163619

Published: 2022

Journal Articles

Analysis of Patient-Level Data from 3 Cooperative Group Trials Confirms a Survival Advantage for NPM1 m Patients Achieving MRD-Negative CR after Intensive Induction

Blood (2022) 140 (Supplement 1): 6293–6294.

https://doi.org/10.1182/blood-2022-159212

Published: 2022

Journal Articles

Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia

Constanze Schneider, Hermes Spaink, Gabriela Alexe, Neekesh V. Dharia, Ashleigh Meyer, Delan Khalid, Sebastian Scheich, Björn Häupl, Louis M. Staudt, Thomas Oellerich, Kimberly Stegmaier

Blood (2022) 140 (Supplement 1): 4936–4937.

https://doi.org/10.1182/blood-2022-168226

Published: 2022

Journal Articles

Proteomic Characterization of Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3456–3457.

https://doi.org/10.1182/blood-2022-169242

Published: 2022

Journal Articles

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Blood (2022) 139 (4): 538–553.

https://doi.org/10.1182/blood.2021012081

Published: 2022

Includes: Supplemental data

Journal Articles

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed N ucleophosmin 1- mutated Acute Myeloid Leukemia

John C. Byrd, Jorge E. Cortes, Mark D. Minden, Thomas Oellerich, Eytan M. Stein, Jenna Elder, Pavan Kumar, Gordon Bray, Jorge DiMartino, Wendy Stock

Blood (2021) 138 (Supplement 1): 1282.

https://doi.org/10.1182/blood-2021-145773

Published: 2021

Journal Articles

Lyn Kinase Contributes to the Reprogramming of Fibroblasts Promoting Chronic Lymphocytic Leukemia Progression

Alexander Frederik Vom Stein, Maximilian Koch, Sebastian Reinarzt, Anna Lucas, Rocio Rebollido-Rios, PhD, Thomas Oellerich, MD, Phuong Hien Nguyen, PhD, Michael Hallek

Blood (2019) 134 (Supplement_1): 4283.

https://doi.org/10.1182/blood-2019-129299

Published: 2019

Journal Articles

KLHL14 Is a Tumor Suppressor in Diffuse Large B-Cell Lymphoma

Jaewoo Choi, PhD, James D Phelan, PhD, Ryan M. Young, PhD, Thomas Oellerich, MD, Da Wei Huang, MD, Arthur L Shaffer, PhD, Louis Staudt, MD

Blood (2019) 134 (Supplement_1): 2766.

https://doi.org/10.1182/blood-2019-125137

Published: 2019

Journal Articles

Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy

The Duy Nguyen, Shabnam Shaid, Olesya Vakhrusheva, Sebastian E. Koschade, Kevin Klann, Marlyn Thölken, Fatima Baker, Jing Zhang, Thomas Oellerich, Duran Sürün, Anja Derlet, Isabella Haberbosch, Stefan Eimer, Heinz D. Osiewacz, Christian Behrends, Christian Münch, Ivan Dikic, Christian H. Brandts

Blood (2019) 133 (2): 168–179.

https://doi.org/10.1182/blood-2018-02-833475

Published: 2019

Includes: Supplemental data

Journal Articles

The Vascular Bone Marrow Niche Influences Outcome in Chronic Myeloid Leukemia

Parimala Sonika Godavarthy, MSc, Stephanie Herkt, Msc, Nina Hayduk, M.Sc, Eva Weissenberger, Yosif Manavski, PhD, Tina Lucas, PhD, Kuan-Ting Pan, PhD, Jenna M. Voutsinas, MSc, Qian V. Wu, PhD, Martin C. Mueller, MD, Thomas Oellerich, MD, Vivian G. Oehler, MD, Jörn Lausen, PhD, Daniela S. Krause, MD

Blood (2018) 132 (Supplement 1): 3846.

https://doi.org/10.1182/blood-2018-99-112398

Published: 2018

Journal Articles

Resistance Mechanisms to SYK Inhibition in AML

Anjali Cremer, MD, Jana M Ellegast, MD, Yana Pikman, MD, Gabriela Alexe, PhD, Linda Ross, PhD, Amy Goodale, Federica Piccioni, PhD, Elizabeth S Frank, Thomas Oellerich, MD, Kimberly Stegmaier, MD

Blood (2018) 132 (Supplement 1): 2638.

https://doi.org/10.1182/blood-2018-99-114996

Published: 2018

Journal Articles

Specific and Targetable Interactions with the Bone Marrow Microenvironment Govern Outcome in Imatinib-Resistant Chronic Myeloid Leukemia

Rahul Kumar, PhD, Maximilian Marten, Bachelors, Valentina Minciacchi, PhD, Raquel Pereira, M.Sc, Costanza Zanetti, MSc, Nina Hyduk, M.Sc, Thomas Oellerich, MD, Hans Michael Kvasnicka, MD, Joel Spencer, PhD, Frank Schnuetgen, PhD, Charles Lin, PhD, Cristina Lo Celso, PhD, Melanie Meister, PhD, Franck Emmanuel Nicolini, MD PhD, Daniela S. Krause, MD

Blood (2018) 132 (Supplement 1): 936.

https://doi.org/10.1182/blood-2018-99-111827

Published: 2018

Journal Articles

Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment

Manar S. Shafat, Thomas Oellerich, Sebastian Mohr, Stephen D. Robinson, Dylan R. Edwards, Christopher R. Marlein, Rachel E. Piddock, Matthew Fenech, Lyubov Zaitseva, Amina Abdul-Aziz, Jeremy Turner, Johnathan A. Watkins, Matthew Lawes, Kristian M. Bowles, Stuart A. Rushworth

Blood (2017) 129 (10): 1320–1332.

https://doi.org/10.1182/blood-2016-08-734798

Published: 2017

Includes: Supplemental data

Journal Articles

HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling

Roland Walter, Kuan-Ting Pan, Carmen Doebele, Federico Comoglio, Katarzyna Tomska, Hanibal Bohnenberger, Ryan M. Young, Laura Jacobs, Ulrich Keller, Halvard Bönig, Michael Engelke, Andreas Rosenwald, Henning Urlaub, Louis M. Staudt, Hubert Serve, Thorsten Zenz, Thomas Oellerich

Blood (2017) 129 (5): 598–608.

https://doi.org/10.1182/blood-2016-06-721423

Published: 2017

Includes: Supplemental data

NARROW

Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Immune Responses after One Versus Two Influenza A/B Vaccinations in Patients with Multiple Myeloma

Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

Analysis of Patient-Level Data from 3 Cooperative Group Trials Confirms a Survival Advantage for NPM1 m Patients Achieving MRD-Negative CR after Intensive Induction

Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia

Proteomic Characterization of Acute Myeloid Leukemia

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed N ucleophosmin 1- mutated Acute Myeloid Leukemia

Lyn Kinase Contributes to the Reprogramming of Fibroblasts Promoting Chronic Lymphocytic Leukemia Progression

KLHL14 Is a Tumor Suppressor in Diffuse Large B-Cell Lymphoma

Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy

The Vascular Bone Marrow Niche Influences Outcome in Chronic Myeloid Leukemia

Resistance Mechanisms to SYK Inhibition in AML

Specific and Targetable Interactions with the Bone Marrow Microenvironment Govern Outcome in Imatinib-Resistant Chronic Myeloid Leukemia

Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment

HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only